Novocure Announces Upcoming Investor Events
: Novocure will host investors on Saturday, May 31 at 8:00 p.m. ET / 7:00 p.m. CT in Chicago to review data from the successful Phase 3 PANOVA-3 clinical trial in unresectable, locally advanced pancreatic cancer. Novocure leadership will be joined by Vincent Picozzi, MD, MMM, medical oncologist and investigator in the PANOVA-3 trial, to review the results and address questions. To request in-person attendance, please contact investor relations at investorinfo@novocure.com.
Jefferies Global Healthcare Conference, June 4, 2025: Ashley Cordova, Chief Executive Officer, will present on behalf of the company and address questions on June 4 at 12:50 p.m. ET. Ms. Cordova will be joined by Christoph Brackmann, Chief Financial Officer, for one-on-one meetings with investors throughout the conference.
Live audio webcasts of these presentations can be accessed from the Investor Relations page of Novocure's website, www.novocure.com/investor-relations, and will be available for replay for at least 14 days following the event.
About Novocure
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure's commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma, non-small cell lung cancer, malignant pleural mesothelioma and pleural mesothelioma. Novocure has several additional ongoing or completed clinical trials exploring the use of Tumor Treating Fields therapy in the treatment of glioblastoma, non-small cell lung cancer and pancreatic cancer.
Novocure's global headquarters is located in Baar, Switzerland, with U.S. headquarters located in Portsmouth, New Hampshire and research and development facilities located in Haifa, Israel. For additional information about the company, please visit Novocure.com and follow @Novocure on LinkedIn and Twitter.
Forward-Looking Statements
In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Novocure's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs, clinical trial progress, development of potential products, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for its products, coverage, collections from third-party payers and other statements regarding matters that are not historical facts. You may identify some of these forward-looking statements by the use of words in the statements such as 'anticipate,' 'estimate,' 'expect,' 'project,' 'intend,' 'plan,' 'believe' or other words and terms of similar meaning. Novocure's performance and financial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, environmental, regulatory and political conditions and other more specific risks and uncertainties facing Novocure such as those set forth in its Annual Report on Form 10-K filed on February 27, 2025, and subsequent filings with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Novocure does not intend to update publicly any forward-looking statement, except as required by law. Any forward-looking statements herein speak only as of the date hereof. The Private Securities Litigation Reform Act of 1995 permits this discussion.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
8 minutes ago
- Business Wire
DLP Capital Named to Inc. 5000 List of Fastest Growing Companies for 13th Consecutive Year
ST. AUGUSTINE, Fla. & BETHLEHEM, Pa.--(BUSINESS WIRE)--DLP Capital, a private real estate investment firm headquartered in Florida and Pennsylvania, announced today that it has been named to the Inc. 5000 list of America's fastest-growing private companies for the 13th year in a row. 'Looking ahead, we aim to multiply our impact on America's housing crisis by bringing Thriving Communities to life across our expanding portfolio of multifamily, build-to-rent, manufactured, and short-term vacation rental homes.' Share The Inc. 5000, published once per year by the New York City-headquartered Inc. Magazine, is an annual ranking of the nation's fastest-growing companies as measured by cumulative revenue growth over the past three years. To be eligible for the 2025 Inc. 5000, companies must be 'privately held, for profit, based in the U.S., and independent.' In addition, contenders must have generated no less than $100,000 in revenue in 2021 and at least $2 million in revenue in 2024 to qualify. 'To be on the Inc. 5000 for 13 years is a rare and remarkable feat,' says Don Wenner, founder and CEO of DLP Capital. 'It's an affirmation of the resounding demand for attainable workforce housing across the country, and a testament to the lasting dedication and trust that our investors, sponsors, residents, and employees have put in us.' This year, DLP ranked #3,821 on the Inc. 5000, #344 in Florida, and #86 in the real estate category. 'Disciplined thought, disciplined people, and disciplined action have led us to where we are today,' says Wenner. 'Looking ahead, we aim to multiply our impact on America's housing crisis by bringing Thriving Communities to life across our expanding portfolio of multifamily, build-to-rent, manufactured, and short-term vacation rental homes.' DLP Capital joins an exclusive cohort of companies that have managed to grow despite inflationary headwinds, high interest rates, and mounting economic uncertainty. This year, the top 500 companies on the Inc. 5000 list achieved a median three-year revenue growth rate of 1,552% and collectively contributed over 48,000 jobs to the American economy during the same period. Inc. magazine will honor this year's awardees at the Inc. 5000 Conference & Gala, which will be held in Phoenix, Arizona from October 22–24, 2025. The Fall issue of Inc. magazine will feature the top 500 companies from the Inc. 5000 list. About DLP Capital: DLP Capital is a St. Augustine, FL and Bethlehem, PA-headquartered private real estate investment firm with over $5.25 billion in assets under management (AUM). Through its four sponsored funds, the firm invests, develops, finances, and operates attainable multifamily and single-family rental housing communities for America's working families. Founded in 2006 by Don Wenner in Pennsylvania's Lehigh Valley, DLP Capital is a thirteen-time Inc. 5000 honoree, most recently in 2025.
Business Insider
19 minutes ago
- Business Insider
Why Is VSee Health Stock Down 55% Today?
VSee Health (VSEE) stock plummeted on Monday after the telehealth company received a notice from The Nasdaq Stock Market LLC's (NDAQ) Listing Qualifications Department. The company is not in compliance with Nasdaq listing rules, including failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024. It has also failed to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2025. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The Listing Qualifications Department has denied VSee Health's request for continued listing. While the company intends to appeal this decision, it expects shares to be delisted from the exchange when markets open on Thursday. When this happens, the company intends for its shares to be listed on OTC Markets (OTCM). VSee Health stock was down 53.79% in pre-market trading on Monday, following a 3.65% dip on Friday. This extended the company's 2.94% drop year-to-date and 38.6% fall over the past 12 months. Is VSee Health Stock a Buy, Sell, or Hold? Turning to Wall Street, analyst coverage of VSee Health is lacking. Luckily, TipRanks' AI analyst Spark has it covered. Spark rates VSEE stock a Neutral (46) with no price target. It cites 'strong revenue growth and recent strategic contracts' as reasons for this stance.
Business Wire
38 minutes ago
- Business Wire
500 Global Launches Sustainable Innovation Program Backed by Catalytic Partners
SAN FRANCISCO--(BUSINESS WIRE)--500 Global, one of the world's most active venture capital firms 1, announced today the launch of its Sustainable Innovation Program, an initiative designed to support mission-driven founders building commercially viable solutions to sustainability challenges across the global south. The true opportunity is within the initiative's potential to mobilize mission-aligned capital and drive venture development across nascent and emerging ecosystems throughout the global south, creating lasting impact at scale. Share Rooted in the belief that the next generation of global growth will be driven by sustainable, inclusive innovation rooted in local leadership, the Sustainable Innovation Program brings together strategic capital, multilateral partnerships, and deep domain expertise to help entrepreneurs scale ventures that deliver both market returns and measurable impact. Their catalytic partner is the Shell Foundation, with co-funding from the UK Government as part of its Transforming Energy Access (TEA) platform and Catalysing Agriculture by Scaling Energy Ecosystems (CASEE) programme. This is the first of these partnerships focused on investing in human capital across agriculture, energy, mobility, and the built environment. ' Through our Sustainable Innovation Program we are supporting commercially viable solutions to critical challenges. We are backing founders who are building businesses that strengthen their communities and scale real impact. Our goal is to support these founders, and our partners, in our shared ambition to create, solve, scale, and sustain inclusive, regenerative societies, to embed values into value creation, and to leverage new partnerships that reshape both regional and global ecosystems for good, ' said Dr. Alaa Murabit, Managing Partner, Sustainable Growth, 500 Global The initiative launches with the Sustainable Innovation Seed Accelerator in Nairobi—an intensive 8-week program for seed-stage startups across Africa. 500 Global will provide participating startups with mentorship and a global network of partners, investors, and operators. 500 Global has been committed to ecosystem development and invested in individuals through entrepreneurship and investor education since 2010. They were embedded early across Latin America, Southeast Asia, the Middle East and North African regions, developing their investment thesis so that by creating localized infrastructure, they may address local challenges and scale those solutions globally. Across their portfolio they have already invested in 140+ companies whose business positively impacts sustainability goals across 27 countries. With the Sustainable Innovation Program, their accelerator in Nairobi is just the beginning. The true opportunity is within the initiative's potential to mobilize mission-aligned capital and drive venture development across nascent and emerging ecosystems throughout the global south, creating lasting impact at scale. 'Partnering with proven investors like 500 Global is a critical element in Shell Foundation's vision of scaling clean solutions to reach millions of customers in emerging economies. Supporting and scaling technologies that are commercial and sustainable will increase incomes while lowering emissions for millions of under-served customers. We're proud to be early partners in what we hope will be a network of sustainable innovation across the global south, ' said Jonathan Berman, CEO of the Shell Foundation. Learn more about the Sustainable Innovation Program and what other cities are on the horizon here. Apply to the Sustainable Innovation Seed Accelerator in Nairobi here. About 500 Global 500 Global is a multi-stage venture capital firm with $2.3B in assets under management 2 that invests in founders building fast-growing technology companies. We focus on markets where technology, innovation, and capital can unlock long-term value and drive economic growth and development. We work closely with key stakeholders and advise governments on how best to support entrepreneurial ecosystems and economic development in emerging markets. 500 Global has backed over 5,000 founders representing more than 3,000 companies operating in 80+ countries. We have invested in more than 35+ companies valued at over $1 billion and 160+ companies valued at over $100 million (including private, public, and exited companies). Our 200+ team members are located in more than 30 countries and bring experience as entrepreneurs, investors, and operators from some of the world's leading technology companies. About Shell Foundation For 25 years, Shell Foundation, an independent charity registered in England and Wales, has empowered underserved customers to raise their incomes while lowering emissions. The Foundation supports early-stage innovations; helps the best of them to reach millions of people; and de-risks capital to prove those models are commercial at scale. Across Asia and Africa, the Foundation enables resilient prosperity among three core groups of people: smallholder farmers, transporters, and micro-entrepreneurs. Find more at THE CONTENT IN THIS PRESS RELEASE IS PROVIDED FOR GENERAL INFORMATIONAL OR EDUCATIONAL PURPOSES ONLY. 500 GLOBAL MAKES NO REPRESENTATIONS AS TO THE ACCURACY OR INFORMATION CONTAINED HEREIN AND WHILE 500 GLOBAL HAS TAKEN REASONABLE STEPS TO ENSURE THAT THE INFORMATION CONTAINED HEREIN IS ACCURATE AND UP-TO-DATE, NO LIABILITY CAN BE ACCEPTED FOR ANY ERROR OR OMISSIONS. UNLESS OTHERWISE STATED IN THIS PRESS RELEASE, ANY PREDICTIONS, FORECASTS, CONCLUSIONS, VIEWS OR OPINIONS EXPRESSED REPRESENT THE CURRENT VIEW AND THINKING OF 500 GLOBAL WITH REGARD TO THE SUBJECT MATTER THEREIN BASED ON INTERNAL DATA AGGREGATED ACROSS ALL 500 GLOBAL FUNDS AS OF OCTOBER 23, 2024 AND/OR ANALYSIS WHICH HAS NOT BEEN INDEPENDENTLY VERIFIED, AND WHICH IS SUBJECT TO CHANGE AT ANY TIME. UNDER NO CIRCUMSTANCES SHOULD ANY OF THE CONTENT IN THIS PRESS RELEASE BE CONSTRUED AS LEGAL, TAX OR INVESTMENT ADVICE FROM 500 GLOBAL OR ANY OF ITS AFFILIATES. 500 GLOBAL DOES NOT GUARANTEE ANY FUTURE RESULTS FOR ANY DECISIONS MADE BASED IN WHOLE OR IN PART ON THE CONTENT OR INFORMATION CONTAINED HEREIN. ALL READERS OF THIS PRESS RELEASE SHOULD CONSULT WITH THEIR OWN COUNSEL, ACCOUNTANT OR OTHER PROFESSIONAL ADVISORS BEFORE TAKING ANY ACTION IN CONNECTION WITH THIS PRESS RELEASE. UNDER NO CIRCUMSTANCES SHOULD ANY INFORMATION OR CONTENT IN THIS PRESS RELEASE BE CONSIDERED AS AN OFFER TO SELL OR SOLICITATION OF INTEREST TO PURCHASE ANY SECURITIES ADVISED BY 500 GLOBAL OR ANY OF ITS AFFILIATES OR REPRESENTATIVES. FURTHER, NO CONTENT OR INFORMATION CONTAINED IN THIS PRESS RELEASE IS OR IS INTENDED AS AN OFFER TO PROVIDE ANY INVESTMENT ADVISORY SERVICE OR FINANCIAL ADVICE BY 500 GLOBAL. UNDER NO CIRCUMSTANCES SHOULD ANYTHING HEREIN BE CONSTRUED AS FUND MARKETING MATERIALS BY PROSPECTIVE INVESTORS CONSIDERING AN INVESTMENT INTO ANY 500 GLOBAL INVESTMENT FUND. UNDER NO CIRCUMSTANCES SHOULD ANY CONTENT BE INTERPRETED AS TESTIMONIALS OR ENDORSEMENT OF THE INVESTMENT PERFORMANCE OF ANY 500 GLOBAL FUND BY A PROSPECTIVE INVESTOR CONSIDERING AN INVESTMENT INTO ANY 500 GLOBAL INVESTMENT FUND.
